Page last updated: 2024-08-16

resveratrol and Myocardial Ischemia

resveratrol has been researched along with Myocardial Ischemia in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.44)18.2507
2000's17 (41.46)29.6817
2010's19 (46.34)24.3611
2020's4 (9.76)2.80

Authors

AuthorsStudies
Lu, J; Ma, Y; Sun, L; Wang, S; Xue, P; Yu, J; Yue, X; Zhang, Y1
Chen, H; Liu, H; Liu, S; Ren, J; Tang, L; Wang, X; Zhao, X; Zhou, T1
Guan, P; Ji, ES; Luo, LF; Qin, LY; Sun, ZM; Wang, N; Zhao, YS1
Bian, ZY; Ding, W; Feng, H; Li, WJ; Liao, HH; Mou, SQ; Zhang, N; Zhou, ZY1
Chen, HP; Deng, YZ; Li, XR; Liu, HY; Ma, ZX; Qiu, LJ; Xu, RY; Xu, XW; Zhao, L1
Dalal, RS; Elmadhun, NY; Robich, MP; Sabe, AA; Sellke, FW2
Das, DK; Das, S; Mitrovsky, G; Vasanthi, HR1
Bianchi, C; Dalal, RS; Elmadhun, NY; Robich, MP; Sabe, AA; Sadek, AA; Sellke, FW1
Cao, F; Chen, Y; Han, D; Ma, S; Wang, J1
Amadio, P; Banfi, C; Barbieri, SS; Brioschi, M; Colombo, GI; Gianellini, S; Ieraci, A; Lee, FS; Parolari, A; Tarantino, E; Tremoli, E; Werba, JP1
Chih, CL; Hu, BR; Huang, SS; Lin, JF; Lin, SM; Nien, MW; Su, HH; Tsai, SK1
Das, DK; Das, S; Dudley, J; Mukherjee, S1
Bertelli, AA; Das, DK; Das, M; Dudley, JI; Lekli, I; Mukherjee, S1
Cacciapuoti, F1
Chen, CJ; Fu, YC; Li, JL; Wang, W; Wang, X; Yu, W1
Bianchi, C; Sellke, FW; Wykrzykowska, JJ1
Chaudray, M; Chu, LM; Clements, RT; Coady, MA; Han, Y; Laham, RJ; Manning, WJ; Nezafat, R; Robich, MP; Sellke, FW1
Bernhagen, J; Bucala, R; Leng, L; Li, J; Ma, H; Merk, M; Ren, J; Thomas, DP; Tong, C; Wang, J; Wang, W; Zierow, S1
Bianchi, C; Boodhwani, M; Clements, RT; Coady, MA; Feng, J; Laham, RJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW1
Das, DK; Gesztelyi, R; Juhasz, A; Juhasz, B; Juhaz, B; Kertesz, A; Varga, B1
Ahsan, K; Bagchi, A; Das, DK; Mukherjee, S; Mukhopadhyay, P; Pacher, P1
Das, DK; Mukhopadhyay, P; Pacher, P1
Chu, LM; Clements, RT; Feng, J; Han, Y; Manning, WJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW1
Burgess, T; Chu, LM; Clements, RT; Feng, J; Laham, RJ; Lassaletta, AD; Robich, MP; Sellke, FW1
Ahsan, MK; Das, DK; Das, S; Mukhopadhyay, P; Otani, H1
Burgess, TA; Chu, LM; Feng, J; Han, Y; Laham, RJ; Leber, MP; Manning, WJ; Nezafat, R; Robich, MP; Sellke, FW1
Bin, J; Chen, B; Chen, C; Liao, Y; Wu, B; Xu, D; Xuan, W; Zhang, W1
Forini, F; Iervasi, G; Sabatino, L1
Barenghi, L; Beemster, P; Bertelli, AA; Bradamante, S; De Jong, JW; De Jonge, R; Piccinini, F2
Dernek, S; Ergun, B; Erkasap, N; Ikizler, M; Kaygisiz, Z; Koken, T; Kural, T; Sevin, B; Yilmaz, K1
Cingolani, HE; Fantinelli, JC; Mosca, SM; Schinella, G1
Akar, F; Aslamaci, S; Coskun, B; Kiziltepe, U; Rakici, O1
Bagchi, D; Das, DK; Das, S; Maulik, N; Tosaki, A1
Jia, GL; Ma, H; Shen, M; Wang, YM1
Bertelli, A; Bertelli, AA; Cordis, GA; Das, DK; Maulik, G; Ray, PS1
Bagchi, D; Das, DK; Maulik, G; Sato, M1
Chen, JK; Huang, SS; Hung, LM; Lee, RS; Su, MJ1
Chan, WF; Chen, JK; Chiao, CW; Chu, WK; Hung, LM; Su, MJ1
Das, DK; Hattori, R; Maulik, N; Otani, H1

Reviews

4 review(s) available for resveratrol and Myocardial Ischemia

ArticleYear
SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease.
    Current drug targets, 2017, Volume: 18, Issue:15

    Topics: Animals; Apoptosis; Disease Models, Animal; Heterocyclic Compounds, 4 or More Rings; Humans; Metabolic Diseases; Molecular Targeted Therapy; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Resveratrol; Sirtuin 1; Stilbenes; Transcriptional Activation

2017
Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: heads and tails of the same coin--resveratrol's role.
    Metabolic syndrome and related disorders, 2009, Volume: 7, Issue:5

    Topics: Animals; Blood Coagulation; Caloric Restriction; Fibrinolytic Agents; Humans; Metabolic Syndrome; Myocardial Ischemia; Resveratrol; Sirtuins; Stilbenes; Thrombosis; Ventricular Function, Left; Wine

2009
Impact of aging on the angiogenic potential of the myocardium: implications for angiogenic therapies with emphasis on sirtuin agonists.
    Recent patents on cardiovascular drug discovery, 2009, Volume: 4, Issue:2

    Topics: Aging; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Collateral Circulation; Coronary Vessels; Humans; Myocardial Ischemia; Resveratrol; Sirtuins; Stilbenes

2009
MicroRNA signatures of resveratrol in the ischemic heart.
    Annals of the New York Academy of Sciences, 2011, Volume: 1215

    Topics: Animals; Humans; MicroRNAs; Myocardial Ischemia; Resveratrol; Stilbenes

2011

Trials

1 trial(s) available for resveratrol and Myocardial Ischemia

ArticleYear
Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery.
    International journal of cardiology, 2005, Nov-02, Volume: 105, Issue:2

    Topics: Acetylcholine; Antioxidants; Coronary Artery Bypass; Endothelium, Vascular; Female; Follow-Up Studies; Humans; In Vitro Techniques; Indomethacin; Male; Mammary Arteries; Middle Aged; Myocardial Ischemia; Norepinephrine; Resveratrol; Saphenous Vein; Stilbenes; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2005

Other Studies

36 other study(ies) available for resveratrol and Myocardial Ischemia

ArticleYear
Establishment of fingerprint and mechanism of anti-myocardial ischemic effect of Syringa pinnatifolia.
    Biomedical chromatography : BMC, 2022, Volume: 36, Issue:11

    Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Creatine Kinase; Eosine Yellowish-(YS); Flavonoids; Hematoxylin; Isoenzymes; Lactate Dehydrogenases; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats; Resveratrol; Syringa; Terpenes

2022
Resveratrol inhibits autophagy against myocardial ischemia-reperfusion injury through the DJ-1/MEKK1/JNK pathway.
    European journal of pharmacology, 2023, Jul-15, Volume: 951

    Topics: Animals; Apoptosis; Autophagy; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Resveratrol

2023
Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation.
    Life sciences, 2020, Mar-15, Volume: 245

    Topics: Animals; Antioxidants; Blotting, Western; Echocardiography; Fluorescent Antibody Technique; Hypoxia; Inflammasomes; Male; Myocardial Ischemia; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol

2020
Resveratrol Inhibits Ischemia-Induced Myocardial Senescence Signals and NLRP3 Inflammasome Activation.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Apoptosis; Biomarkers; Cell Hypoxia; Heart Function Tests; Inflammasomes; Male; Mice, Inbred C57BL; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Sprague-Dawley; Resveratrol; Risk Factors; Signal Transduction

2020
Resveratrol attenuates myocardial hypoxia/reoxygenation-induced cell apoptosis through DJ-1-mediated SIRT1-p53 pathway.
    Biochemical and biophysical research communications, 2019, 06-25, Volume: 514, Issue:2

    Topics: Acetylation; Animals; Apoptosis; Cardiotonic Agents; Cell Hypoxia; Cell Line; Cell Survival; Enzyme Activation; L-Lactate Dehydrogenase; Myocardial Ischemia; Myocardial Reperfusion Injury; Protein Binding; Protein Deglycase DJ-1; Rats; Resveratrol; Sirtuin 1; Tumor Suppressor Protein p53

2019
Does resveratrol improve insulin signaling in chronically ischemic myocardium?
    The Journal of surgical research, 2013, Volume: 183, Issue:2

    Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Disease Models, Animal; Glucose; Insulin; Male; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Resveratrol; Signal Transduction; Stilbenes; Swine

2013
Resveratrol regulates autophagy signaling in chronically ischemic myocardium.
    The Journal of thoracic and cardiovascular surgery, 2014, Volume: 147, Issue:2

    Topics: Animals; Apoptosis Regulatory Proteins; Autophagy; Blotting, Western; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Lysosomal-Associated Membrane Protein 2; Male; Microtubule-Associated Proteins; Myocardial Ischemia; Myocardium; Phosphorylation; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Swine; Swine, Miniature; Time Factors; TOR Serine-Threonine Kinases

2014
Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN.
    Oxidative medicine and cellular longevity, 2014, Volume: 2014

    Topics: Aging; Animals; Antioxidants; Apoptosis; Blotting, Western; Fluorescent Antibody Technique; Forkhead Box Protein O3; Forkhead Transcription Factors; Glutathione; Heart Ventricles; In Vitro Techniques; Intracellular Space; Male; Mitochondrial Dynamics; Mitophagy; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuins; Stilbenes; Ubiquitin-Protein Ligases; Vitis

2014
Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis.
    Journal of medicinal food, 2015, Volume: 18, Issue:1

    Topics: Animals; Antioxidants; Biomarkers; Cell Death; Cholesterol, Dietary; Coronary Vessels; Dietary Supplements; Disease Models, Animal; Heart; Male; Metabolic Syndrome; Mitochondria; Myocardial Ischemia; Myocardium; Phytotherapy; Plant Extracts; Proteins; Proteomics; Resveratrol; Signal Transduction; Stilbenes; Swine

2015
BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.
    European heart journal, 2017, May-07, Volume: 38, Issue:18

    Topics: Animals; Anxiety Disorders; Aorta; Blood Coagulation; Brain-Derived Neurotrophic Factor; Carotid Arteries; Carotid Artery Thrombosis; Depressive Disorder; Disease Models, Animal; Female; Heterozygote; Homozygote; Humans; Male; Mice, Transgenic; Middle Aged; Myocardial Ischemia; Nerve Tissue Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Receptors, Cell Surface; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Thrombosis

2017
Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats.
    Life sciences, 2008, Aug-29, Volume: 83, Issue:9-10

    Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Collagen Type I; Echocardiography; Hemodynamics; Male; Mice; Myocardial Ischemia; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Transforming Growth Factor beta1; Ventricular Remodeling

2008
Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose.
    The Journal of nutritional biochemistry, 2009, Volume: 20, Issue:6

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Male; Myocardial Ischemia; NF-kappa B; Oxidation-Reduction; Phytoalexins; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Signal Transduction; Stilbenes; Terpenes; Wine

2009
Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol.
    Journal of agricultural and food chemistry, 2008, Oct-22, Volume: 56, Issue:20

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Cardiotonic Agents; Heart; Humans; In Vitro Techniques; Male; Mitochondrial Swelling; Myocardial Ischemia; Myocardium; Peroxides; Phenylethyl Alcohol; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine

2008
Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway.
    Biochemical and biophysical research communications, 2009, Jan-16, Volume: 378, Issue:3

    Topics: Animals; Antioxidants; Apoptosis; Cell Hypoxia; Cells, Cultured; Cytoprotection; Forkhead Transcription Factors; Myocardial Ischemia; Myocytes, Cardiac; Nerve Tissue Proteins; Rats; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes

2009
Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome.
    Surgery, 2010, Volume: 148, Issue:2

    Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Antigens, CD; Cadherins; Cholesterol, Dietary; Collateral Circulation; Coronary Angiography; Disease Models, Animal; Magnetic Resonance Imaging; Male; Metabolic Syndrome; Myocardial Ischemia; Neovascularization, Physiologic; Resveratrol; Stilbenes; Swine; Swine, Miniature

2010
Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart.
    Circulation, 2010, Jul-20, Volume: 122, Issue:3

    Topics: Aging; AMP-Activated Protein Kinases; Animals; Down-Regulation; Enzyme Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Phenotype; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes; Ultrasonography; Ventricular Function, Left

2010
Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia.
    Circulation, 2010, Sep-14, Volume: 122, Issue:11 Suppl

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillaries; Chronic Disease; Coronary Circulation; Coronary Disease; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Male; Microcirculation; Myocardial Ischemia; Myocardium; Neovascularization, Physiologic; Perfusion; Resveratrol; Signal Transduction; Stilbenes; Swine; Vascular Endothelial Growth Factor A

2010
Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]
    Molecular and cellular biochemistry, 2011, Volume: 348, Issue:1-2

    Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Biomarkers; Cholesterol; Disease Models, Animal; Down-Regulation; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Resveratrol; Stilbenes; Time Factors; Ventricular Function, Left; Ventricular Pressure

2011
Restoration of altered microRNA expression in the ischemic heart with resveratrol.
    PloS one, 2010, Dec-23, Volume: 5, Issue:12

    Topics: Animals; Cardiotonic Agents; Computational Biology; Heart; Male; Mice; MicroRNAs; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Software; Stilbenes

2010
Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia.
    European journal of pharmacology, 2011, Aug-16, Volume: 664, Issue:1-3

    Topics: Animals; Biomarkers; Cholesterol; Coronary Artery Disease; Diet; Dietary Supplements; Fatty Acids, Nonesterified; Gene Expression Regulation; Glucose Tolerance Test; Glucose Transporter Type 4; Heart; Inflammation; Insulin; Magnetic Resonance Imaging; Metabolic Syndrome; Microvessels; Muscle Cells; Myocardial Ischemia; Oxidation-Reduction; Protein Transport; Resveratrol; Risk Factors; Stilbenes; Swine

2011
Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia.
    Surgery, 2011, Volume: 150, Issue:3

    Topics: Administration, Oral; Animals; Blood Chemical Analysis; Coronary Angiography; Coronary Circulation; Disease Models, Animal; Drug Therapy, Combination; Hypercholesterolemia; Immunoblotting; Immunohistochemistry; Male; Myocardial Ischemia; Neovascularization, Physiologic; Oxidative Stress; Phosphorylation; Random Allocation; Reference Values; Resveratrol; Risk Factors; Sensitivity and Specificity; Stilbenes; Swine; Vascular Endothelial Growth Factor A

2011
Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:10

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Chromans; Down-Regulation; Drug Synergism; Gene Expression Profiling; Heart; Hypoxia-Inducible Factor 1, alpha Subunit; Male; MicroRNAs; Microscopy, Confocal; Multivariate Analysis; Myocardial Ischemia; Myocardium; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Vascular Endothelial Growth Factor A; Vitamin E

2012
Resveratrol preserves myocardial function and perfusion in remote nonischemic myocardium in a swine model of metabolic syndrome.
    Journal of the American College of Surgeons, 2012, Volume: 215, Issue:5

    Topics: Animals; Antioxidants; Biomarkers; Blotting, Western; Coronary Vessels; Diet, High-Fat; Disease Models, Animal; Fluorescent Antibody Technique; Heart; Magnetic Resonance Imaging; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Oxidative Stress; Resveratrol; Stilbenes; Swine; Ventricular Function, Left

2012
Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*.
    Critical care medicine, 2012, Volume: 40, Issue:11

    Topics: Animals; Animals, Newborn; Chemokine CX3CL1; Disease Models, Animal; Electrocardiography; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Platelet Aggregation Inhibitors; Random Allocation; Rats; Resveratrol; Stilbenes; Ventricular Remodeling

2012
A glass of wine: how good is good? The resveratrol lesson*.
    Critical care medicine, 2012, Volume: 40, Issue:11

    Topics: Animals; Chemokine CX3CL1; Heart Failure; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes

2012
Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
    European journal of pharmacology, 2003, Mar-28, Volume: 465, Issue:1-2

    Topics: Adenosine; Animals; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Theophylline; Time Factors; Vasodilator Agents

2003
Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia.
    Scandinavian cardiovascular journal : SCJ, 2004, Volume: 38, Issue:4

    Topics: Analysis of Variance; Animals; Coronary Circulation; Disease Models, Animal; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Sensitivity and Specificity; Stilbenes; Survival Rate

2004
Effects of different fractions of a red wine non-alcoholic extract on ischemia-reperfusion injury.
    Life sciences, 2005, Apr-22, Volume: 76, Issue:23

    Topics: Animals; Argentina; Blood Pressure; Cardiotonic Agents; Flavonols; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenols; Rats; Rats, Wistar; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances; Ventricular Function, Left; Wine

2005
Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 317, Issue:3

    Topics: Animals; Cardiotonic Agents; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardial Ischemia; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes

2006
Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats.
    Vascular pharmacology, 2006, Volume: 45, Issue:2

    Topics: Animals; Antioxidants; Cardiotonic Agents; Free Radical Scavengers; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Up-Regulation

2006
The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury.
    Free radical biology & medicine, 1999, Volume: 27, Issue:1-2

    Topics: Animals; Antioxidants; Free Radicals; Heart; In Vitro Techniques; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Peroxides; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine

1999
Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin.
    Free radical research, 2000, Volume: 32, Issue:2

    Topics: Animals; Antioxidants; Blood Pressure; Coronary Vessels; Emodin; Fluoresceins; Free Radical Scavengers; Gamma Rays; Hydroxyl Radical; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Oxidative Stress; Peroxides; Polygonaceae; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes

2000
Does resveratrol induce pharmacological preconditioning?
    International journal of tissue reactions, 2000, Volume: 22, Issue:1

    Topics: Adenosine; Animals; Antioxidants; Cardiovascular Physiological Phenomena; Heart; Ischemic Preconditioning, Myocardial; Male; Muscle Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phosphates; Phosphorylation; Rats; Rats, Sprague-Dawley; Recovery of Function; Regional Blood Flow; Reperfusion Injury; Resveratrol; Stilbenes

2000
Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.
    Cardiovascular research, 2000, Aug-18, Volume: 47, Issue:3

    Topics: Analysis of Variance; Animals; Antioxidants; Blood Pressure; Chi-Square Distribution; Free Radical Scavengers; Heart Rate; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Statistics, Nonparametric; Stilbenes; Tachycardia, Ventricular; Ventricular Fibrillation

2000
The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy.
    British journal of pharmacology, 2002, Volume: 135, Issue:7

    Topics: Animals; Biphenyl Compounds; Disease Models, Animal; Free Radical Scavengers; Humans; Lipoproteins, LDL; Male; Myocardial Ischemia; Oxidation-Reduction; Picrates; Protective Agents; Rats; Rats, Inbred WKY; Reperfusion Injury; Resveratrol; Stilbenes; Superoxides

2002
Pharmacological preconditioning with resveratrol: role of nitric oxide.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:6

    Topics: Animals; Apoptosis; Enzyme Inhibitors; Gene Expression; Guanidines; Heart Ventricles; Ischemic Preconditioning; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes

2002